Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal...

43
Developing an Developing an Effective Oral Effective Oral Analgesic Regimen Analgesic Regimen Theresa Kristopaitis, MD Theresa Kristopaitis, MD Department of Internal Medicine, Department of Internal Medicine, Division of General Medicine Division of General Medicine Associate Medical Director, Loyola Associate Medical Director, Loyola Hospice Hospice

Transcript of Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal...

Page 1: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Developing an Effective Developing an Effective Oral Analgesic RegimenOral Analgesic Regimen

Theresa Kristopaitis, MDTheresa Kristopaitis, MDDepartment of Internal Medicine, Division of Department of Internal Medicine, Division of

General MedicineGeneral MedicineAssociate Medical Director, Loyola HospiceAssociate Medical Director, Loyola Hospice

Page 2: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

General PrinciplesGeneral Principles

Assess pain thoroughlyAssess pain thoroughly

Know your patientKnow your patient

Know the medicationsKnow the medications

Dose to reduce pain by at least 50%Dose to reduce pain by at least 50%

Reassess frequentlyReassess frequently

Page 3: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

PainPain

Pain is a personal, complex experience Pain is a personal, complex experience with 3 componentswith 3 components SensorySensory EmotionalEmotional CognitiveCognitive

Page 4: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

ReviewReview

Neuroscience lectures on pain physiology!Neuroscience lectures on pain physiology!

P&T lectures on NSAIDs and opiates!P&T lectures on NSAIDs and opiates!

Page 5: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Pain pathophysiologyPain pathophysiology

Acute painAcute pain identified event, resolves days–weeksidentified event, resolves days–weeks usually nociceptiveusually nociceptive

Chronic painChronic pain cause often not easily identified, multifactorialcause often not easily identified, multifactorial indeterminate durationindeterminate duration nociceptive and / or neuropathicnociceptive and / or neuropathic

Nociceptive pain – results from actual or potential tissue damage. Resultof ongoing activation of nociceptors on primary afferent nerves bynoxious stimuliSomative vs visceral

Page 6: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

WHO 3-Step LadderWHO 3-Step Ladder

Step 1 - Mild

Step 2 - Moderate

Step 3 - Severe

Aspirin

Acetaminophen

NSAIDs

Codeine/…

Hydrocodone/…

Oxycodone/…

…/acetaminophenor NSAID

Tramadol

Morphine

Hydromorphone

Methadone

Oxycodone

Fentanyl

Always consider adding an adjuvant Rx

Page 7: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

““Adjuvant Analgesic”Adjuvant Analgesic”

Drug which has a primary indication other than Drug which has a primary indication other than pain managementpain managementActs as analgesic in some painful conditionsActs as analgesic in some painful conditions AntidepressantsAntidepressants CorticosteroidsCorticosteroids AnticonvulsantsAnticonvulsants Local anestheticsLocal anesthetics Osteoclast inhibitorsOsteoclast inhibitors RadiopharmaceuticalsRadiopharmaceuticals Muscle relaxantsMuscle relaxants BenzodiazepenesBenzodiazepenes

Page 8: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Our CaseOur Case

• Continuous pain Continuous pain

• Moderate intensityModerate intensity

• Chronic, non-neuropathicChronic, non-neuropathic

• Worsens with certain activitesWorsens with certain activites

Page 9: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Where to begin?Where to begin?

• Begin low dose immediate Begin low dose immediate release oral opioidrelease oral opioid

• ExamplesExamples• Hydrocodone 5mgHydrocodone 5mg• Morphine 5mgMorphine 5mg• Oxycodone 3mgOxycodone 3mg• Hydromorphone 1mgHydromorphone 1mg

Hospice and Palliative Care Training for Physicians: UNIPAC 3Assessment and Treatment of Physical Pain Associated with Life-Limiting Illness, CP Storey et al, ed

EPERC, Fast Facts

Page 10: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Community Service AnnouncementCommunity Service Announcement

Page 11: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Opioids vs NarcoticsOpioids vs Narcotics

OpioidOpioid Naturally occurring, semisynthetic, and Naturally occurring, semisynthetic, and

synthetic drugs which produce effects by synthetic drugs which produce effects by combining with opioid receptors and combining with opioid receptors and antagonized by nalaxoneantagonized by nalaxone

NarcoticNarcotic ““numbness” or “stupor”numbness” or “stupor” Describes morphine like drugs and drugs of Describes morphine like drugs and drugs of

abuse (including coca/cocaine derivates) abuse (including coca/cocaine derivates)

Page 12: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Opioids Opioids vs Narcoticsvs Narcotics

““Who’s got the narc keys?”Who’s got the narc keys?”

““Who’s got the opioid keys?”Who’s got the opioid keys?”

Page 13: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Immediate Release Oral OpioidImmediate Release Oral OpioidAdministered as Administered as single agents single agents combination productscombination products

Peak analgesic effect occurs in 60-90 minutesPeak analgesic effect occurs in 60-90 minutesExpected total duration of analgesia of 2-4 Expected total duration of analgesia of 2-4 hours. hours. Standard reference sources generally cite a 4 Standard reference sources generally cite a 4 hour dosing interval for the single-agent opioidshour dosing interval for the single-agent opioids 4-6 or 6 hour intervals for combination products 4-6 or 6 hour intervals for combination products

Agency for Health Care Policy and Research (AHCPR) Agency for Health Care Policy and Research (AHCPR) Clinical Practice Guideline (1994) recommends dosing Clinical Practice Guideline (1994) recommends dosing intervals for all short-acting opioids at an interval or every 3-4 intervals for all short-acting opioids at an interval or every 3-4 hours, an interval more consistent with patient reports of pain hours, an interval more consistent with patient reports of pain relief and the half-life of oral opioids. relief and the half-life of oral opioids.

Page 14: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Combination opiate/nonopiateCombination opiate/nonopiate

-50 different opioid combination products-50 different opioid combination products• Contain either acetaminophen, aspirin or Contain either acetaminophen, aspirin or

ibuprofen, with an opioidibuprofen, with an opioid• range of tablet strengths and liquidsrange of tablet strengths and liquids• typically used for moderate pain that is typically used for moderate pain that is

episodic episodic • For persistent pain administered on around-the-For persistent pain administered on around-the-

clock basisclock basis

Page 15: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Step 2 Opioid CombosStep 2 Opioid Combos

PotencyPotency Oxycodone > hydrocodone > codeineOxycodone > hydrocodone > codeine

Propoxyphene = aspirin or acetaminophenPropoxyphene = aspirin or acetaminophen

The dose limiting property of all the The dose limiting property of all the combination products is?combination products is? aspirin, acetaminophen or NSAIDaspirin, acetaminophen or NSAID

Page 16: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

WHO Step 2WHO Step 2TramadolTramadol

Centrally acting synthetic analgesicCentrally acting synthetic analgesic opioid receptor bindingopioid receptor binding Weak inhibition of serotonin uptakeWeak inhibition of serotonin uptake Weak inhibition of norepinephrine uptakeWeak inhibition of norepinephrine uptake

Cautions:Cautions: Serotonin syndromeSerotonin syndrome Lowers seizure thresholdLowers seizure threshold

Page 17: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Our patientOur patient

On Percocet On Percocet Combination opioid/nonopioidCombination opioid/nonopioid

Oxycodone/acetaminophenOxycodone/acetaminophen

StrengthsStrengths 2.5/3252.5/325 5/3255/325 7.5/3257.5/325 7.5/5007.5/500 10/32510/325 10/65010/650

Page 18: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Initial PlanInitial Plan

Oxycodone/acetaminophen Oxycodone/acetaminophen 2.5/325 q 6 hours2.5/325 q 6 hours

Not helping - still 5-6/10 painNot helping - still 5-6/10 pain TitrationTitration

Increase 25-50% for mild-moderate painIncrease 25-50% for mild-moderate painIncrease 50-100% for moderate – severe painIncrease 50-100% for moderate – severe pain

Most short acting opiates can be safely titrated every 2 Most short acting opiates can be safely titrated every 2 hourshours

Side effect evaluationSide effect evaluationSedationSedation

Page 19: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

EPIC In-BoxEPIC In-Box

Oxycodone/acetaminophen Oxycodone/acetaminophen • 5/325 tab5/325 tab

• 1-2 tabs every 6 hours as needed1-2 tabs every 6 hours as needed

Page 20: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Case Options?Case Options?Increase dose of oxycodone/acetaminophen?Increase dose of oxycodone/acetaminophen? 10/325 tabs – take 1 ½, not relieved, take 210/325 tabs – take 1 ½, not relieved, take 2

Change dosing interval?Change dosing interval? Q 4 hoursQ 4 hours

Scheduled vs PRN dosing?Scheduled vs PRN dosing? ScheduledScheduled

Change to another opiate combo?Change to another opiate combo? Oxycodone most potentOxycodone most potent

Change to non-combo opiate?Change to non-combo opiate? Soon - reaching acetaminophen maxSoon - reaching acetaminophen max

Add breakthrough dose of opiate?Add breakthrough dose of opiate? Yes, but will need an agent without acetaminophenYes, but will need an agent without acetaminophen

Add an adjuvant?Add an adjuvant? Re-evaluarte characteristics of painRe-evaluarte characteristics of pain

Begin long acting opiate?Begin long acting opiate? When stable daily dosage requirements determinedWhen stable daily dosage requirements determined

Page 21: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

PlanPlan

Oxycodone 10/325Oxycodone 10/325 1 1/2 tabs q 4 hours scheduled1 1/2 tabs q 4 hours scheduled 2 days later, a little better, not sleepy2 days later, a little better, not sleepy 2 tabs q 4hours scheduled2 tabs q 4hours scheduled

Titrated oxycodone from 40mg /24 hours to 120mg/24 Titrated oxycodone from 40mg /24 hours to 120mg/24 hourshours

(acetaminophen 3900mg/24 hours)(acetaminophen 3900mg/24 hours)

Relief!!Relief!!

Page 22: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Q 4 hour ATC meds?Q 4 hour ATC meds?

Page 23: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Extended-release opiate Extended-release opiate preparationspreparations

Improve compliance, adherenceImprove compliance, adherence

Page 24: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Extended Release OpiatesExtended Release Opiates

NEVER!!!!!NEVER!!!!!In opiate naïve patients!!!!!In opiate naïve patients!!!!!

Page 25: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Extended Release PreparationsExtended Release Preparations

Extended Release Oral MorphineExtended Release Oral Morphine

Extended Release Oral OxycodoneExtended Release Oral Oxycodone

Transdermal FentanylTransdermal Fentanyl

Page 26: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Extended-release opiate Extended-release opiate preparationspreparations

MorphineMorphine Morphine ER, MS Contin, Kadian, AvinzaMorphine ER, MS Contin, Kadian, Avinza

OxycodoneOxycodone Oxycodone ER, OxycontinOxycodone ER, Oxycontin

FentanylFentanyl Transderm patch (Duragesic) Transderm patch (Duragesic)

Page 27: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Extended-release opioid Extended-release opioid preparationspreparations

Dose q 8, 12, or 24 h (product specific)Dose q 8, 12, or 24 h (product specific) Don’t crush or chew capsulesDon’t crush or chew capsules No capsules down feeding tubesNo capsules down feeding tubes

may flush time-release granules (Kadian) down feeding may flush time-release granules (Kadian) down feeding tubestubes

Adjust dose q 2–4 days (once steady state Adjust dose q 2–4 days (once steady state reached)reached)

Fentanyl transderm q 72 hoursFentanyl transderm q 72 hours Adjust dose at 6 days (once steady state achieved)Adjust dose at 6 days (once steady state achieved)

Page 28: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Extended-release opioid Extended-release opioid preparationspreparations

Should not be used for rapid titration in Should not be used for rapid titration in patients with severe painpatients with severe pain

Page 29: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Case - How?Case - How?

Oxycodone 10/325Oxycodone 10/325 2 tabs q 4 hours2 tabs q 4 hours

120mg oxycodone/24 hours120mg oxycodone/24 hours

Oxycodone ER 60mg q 12 hoursOxycodone ER 60mg q 12 hours

Page 30: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Could we use extended release Could we use extended release morphine?morphine?

Could we use transdermal fentanyl?Could we use transdermal fentanyl?

Page 31: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

FentanylFentanyl

Lipid soluble Lipid soluble

-Crosses skin and oral mucosa-Crosses skin and oral mucosa

Transdermal fentanylTransdermal fentanyl 25 25 g patch g patch 45–135 (likely 50–60) mg PO 45–135 (likely 50–60) mg PO

morphine / 24 h morphine / 24 h 12 12 g patch is available nowg patch is available now

Page 32: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Fentanyl Transdermal PatchFentanyl Transdermal Patch

onset after application onset after application 24 hours 24 hours

effect 72 hours (some patients 48 hours)effect 72 hours (some patients 48 hours)

ensure adherence to skinensure adherence to skin

increased absorption with increased body increased absorption with increased body temptemp

may not be as effective in cachexia may not be as effective in cachexia (minimal adipose tissue) (minimal adipose tissue)

Page 33: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Our patient Our patient

Convert to FentanylConvert to Fentanyl Oxycodone 120mg/24 hoursOxycodone 120mg/24 hours

Page 34: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Equianalgesic dosesEquianalgesic dosesof opioid analgesicsof opioid analgesics

po / pr (mg)po / pr (mg) AnalgesicAnalgesic SC / IV / IM (mg)SC / IV / IM (mg)

100100 CodeineCodeine 6060

1515 HydrocodoneHydrocodone --

44 HydromorphoneHydromorphone 1.51.5

1515 MorphineMorphine 55

1010 OxycodoneOxycodone --

Page 35: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

ConversionConversion

Oxycodone 120mg x Oxycodone 120mg x Morphine 15mgMorphine 15mg Oxycodone 10mgOxycodone 10mg=180mg morphine equivalent=180mg morphine equivalent

25 25 g patch g patch 50 mg PO morphine / 24 h 50 mg PO morphine / 24 h

Fentanyl 75mcg/hr patch q 72 hrsFentanyl 75mcg/hr patch q 72 hrs

Page 36: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Breakthrough PainBreakthrough Pain

IncidentIncident Activity related, identifiable precipitantActivity related, identifiable precipitant

Anticipate and premedicate with short acting agentsAnticipate and premedicate with short acting agents

Idiopathic, spontaneousIdiopathic, spontaneous UnpredictableUnpredictable PRN opiate, consider adjuvantPRN opiate, consider adjuvant

End-of-dose failureEnd-of-dose failure Increase dose or shorten time between doses of long-Increase dose or shorten time between doses of long-

acting agentacting agent

Page 37: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Breakthrough PainBreakthrough Pain

Use immediate-release opioidsUse immediate-release opioids 10%–15% of 24-hr dose10%–15% of 24-hr dose offer after Coffer after Cmaxmax reached reached

po po q 1hr q 1hr

or 50% regular 4 hour doseor 50% regular 4 hour dose

Do NOT use extended-release opioidsDo NOT use extended-release opioids

Page 38: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Our CaseOur Case

Oxycodone 120mg/24 hoursOxycodone 120mg/24 hours 10-15%10-15%

Oxycodone 15mg PO q 1 hour PRN Oxycodone 15mg PO q 1 hour PRN breakthrough painbreakthrough pain

Page 39: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Follow-upFollow-up

Oxycodone ER 120mg q 12 hoursOxycodone ER 120mg q 12 hoursOxycodone 15mg breakthroughOxycodone 15mg breakthrough 3 weeks later EPIC in-box3 weeks later EPIC in-box Has taken 4 breakthrough doses daily x 2 daysHas taken 4 breakthrough doses daily x 2 days

Re-evaluate painRe-evaluate pain

60mg additional oxycodone60mg additional oxycodoneIncrease oxycodone ER toIncrease oxycodone ER to 150mg q 12 hours150mg q 12 hours

New breakthrough dose?New breakthrough dose? Oxycodone 30mg q 1 hours PRNOxycodone 30mg q 1 hours PRN

Page 40: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Bowel regimenBowel regimen

Page 41: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Final ThoughtsFinal Thoughts

Physical pain is the most common source Physical pain is the most common source of “suffering”of “suffering”

Page 42: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Total PainTotal Pain

Dame Cicely SaundersDame Cicely Saunders

Physical Physical

EmotionalEmotional

SocialSocial

SpiritualSpiritual

Page 43: Developing an Effective Oral Analgesic Regimen Theresa Kristopaitis, MD Department of Internal Medicine, Division of General Medicine Associate Medical.

Questions?Questions?